Central Retinal Vein Occlusion

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Functional Optical Coherence Tomography for Ocular Imaging

Completed
  • Glaucoma
  • +4 more
  • Optical Coherence Tomography
  • Irvine, California
    Beckman Laser Institute, University of California,Irvine
Oct 19, 2022

Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)

Completed
  • Glaucoma
  • +12 more
  • Free Eye Screenings
  • +2 more
  • Philadelphia, Pennsylvania
    Wills Eye Glaucoma Service
Aug 19, 2022

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting
  • Macular Edema
  • +2 more
  • Mesa, Arizona
  • +193 more
Jul 25, 2022

Central Retinal Vein Occlusion Trial in Paris, Strasbourg, Écully (Ophthalmologic exam at inclusion and 12 months after CRVO,

Recruiting
  • Central Retinal Vein Occlusion
  • Ophthalmologic exam at inclusion and 12 months after CRVO
  • Treatment standardization with aflibercept
  • Paris, France
  • +2 more
Oct 19, 2021

Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)

Completed
  • Central Retinal Vein Occlusion
  • Phoenix, Arizona
  • +71 more
Jun 11, 2021

Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)

Completed
  • Retinal Vein Occlusion
  • +3 more
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
May 10, 2021

Central Retinal Vein Occlusion Trial in TianJing (601 1.25mg, Ranibizuman 0.5 mg)

Not yet recruiting
  • Central Retinal Vein Occlusion
  • 601 1.25mg
  • Ranibizuman 0.5 mg
  • TianJing, TianJing, China
    TianJing Medical University Eye Hospital
Dec 8, 2020

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Central Retinal Vein Occlusion Trial in Shenyang (Bevacizumab Ophthalmic and Intravitreal Dexamethasone., Bevacizumab

Unknown status
  • Central Retinal Vein Occlusion
  • Bevacizumab Ophthalmic and Intravitreal Dexamethasone.
  • Bevacizumab Ophthalmic.
  • Shenyang, Liaoning, China
    He Eye Specialist Hospital
Oct 20, 2020

Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))

Completed
  • Central Retinal Vein Occlusion
  • Aflibercept (Eylea, BAY86-5321)
  • Albury, New South Wales, Australia
  • +41 more
Jun 19, 2020

Central Retinal Vein Occlusion Trial in Leuven (Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse)

Completed
  • Central Retinal Vein Occlusion
  • Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse) infusion up to 1mg.
  • Intravenous Infusion
  • Leuven, Vlaams Brabant, Belgium
    UZ Leuven
May 6, 2020

Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion Trial in Palo Alto (nicotinic acid)

Terminated
  • Central Retinal Vein Occlusion
  • Branch Retinal Vein Occlusion
  • nicotinic acid
  • Palo Alto, California
    Palo Alto Medical Foundation Department of Ophthalmology
Oct 21, 2019

Central Retinal Vein Occlusion Trial in New York (Tissue Plasminogen Activator)

Completed
  • Central Retinal Vein Occlusion
  • Tissue Plasminogen Activator
  • New York, New York
    Weill Cornell Medical College/ New York Presbyterian hospital
Aug 2, 2018

Macular Edema, Central Retinal Vein Occlusion Trial in United States (Ozurdex, Avastin)

Completed
  • Macular Edema
  • Central Retinal Vein Occlusion
  • Toms River, New Jersey
  • +3 more
Mar 5, 2018

Central Retinal Vein Occlusion Trial in Leuven (Ocriplasmin intravenously)

Completed
  • Central Retinal Vein Occlusion
  • Ocriplasmin intravenously
  • Leuven, Vlaams Brabant, Belgium
    UZ Leuven
Jan 4, 2018

Central Retinal Vein Occlusion Trial in Worldwide (Sham injection, Ranibizumab 0.5 mg)

Completed
  • Central Retinal Vein Occlusion
  • Sham injection
  • Ranibizumab 0.5 mg
  • Beijing, Beijing, China
  • +33 more
Apr 24, 2017

Central Retinal Vein Occlusion- a Prospective Controlled Study

Completed
  • Vitamin d Deficiency
  • Central Retinal Vein Occlusion
    • Stockholm, Sweden
      St Eriks Eye Hospital
    Nov 23, 2016

    Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab 0.5 mg/0.05 ml)

    Completed
    • Macular Edema
    • Central Retinal Vein Occlusion
    • Ranibizumab 0.5 mg/0.05 ml
    • Parramatta, New South Wales, Australia
    • +77 more
    Sep 21, 2016

    Visual Impairment, Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab, Dexamethasone implant and sham

    Completed
    • Visual Impairment
    • +2 more
    • Augsburg, Germany
    • +63 more
    Sep 21, 2016

    Macular Edema, Central Retinal Vein Occlusion Trial in United States (Ozurdex, Ranibizumab, Combination Ozurdex with Ranibizumab

    Unknown status
    • Macular Edema
    • Central Retinal Vein Occlusion
    • Beverly Hills, California
    • +4 more
    Dec 10, 2015

    Central Retinal Vein Occlusion, Proliferative Diabetic Retinopathy Trial in Boston (Intravitreal Aflibercept Injection)

    Completed
    • Central Retinal Vein Occlusion
    • Proliferative Diabetic Retinopathy
    • Intravitreal Aflibercept Injection
    • Boston, Massachusetts
      Ophthalmic Consultants of Boston
    May 21, 2015

    Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Macular Edema Trial in United States (ranibizumab 0.5mg,

    Completed
    • Branch Retinal Vein Occlusion
    • +2 more
    • ranibizumab 0.5mg
    • ranibizumab 1.0mg
    • Huntington Beach, California
    • +3 more
    Apr 10, 2015

    Central Retinal Vein Occlusion Trial in Zerifin (Hyperbaric chamber treatment)

    Unknown status
    • Central Retinal Vein Occlusion
    • Hyperbaric chamber treatment
    • Zerifin, Israel
      Assaf Harofe MC
    Mar 31, 2015

    Central Retinal Vein Occlusion Trial in Creteil, Paris (ranibizumab, hemodilution)

    Completed
    • Central Retinal Vein Occlusion
    • Creteil, France
    • +1 more
    Aug 12, 2014

    Central Retinal Vein Occlusion Trial in Durham (fluocinolone acetonide (Retisert Implant, Bausch and Lomb))

    Completed
    • Central Retinal Vein Occlusion
    • fluocinolone acetonide (Retisert Implant, Bausch and Lomb)
    • Durham, North Carolina
      Duke Eye Center
    Aug 1, 2014